Procoagulant peptides and use thereof
AssigneeRambam Med-Tech Ltd.
InventorYona NADIR
Life of this patent
Estimating the term…
Abstract
There is provided procoagulant peptides, and use of same, such as in treatment of hemostasis-related diseases or disorders, and/or wound healing.
Claims26
A peptide of 6 to 25 amino acids comprising SEQ ID NO:
- 1 (KRRKLR), or a functional analog thereof, comprising a C-terminal amid group, and optionally wherein said peptide further comprises an N-terminal acyl group.
(canceled)
-8. (canceled)
(canceled)
A method for treating a subject in need of wound healing, the method comprising administering to said subject a therapeutically effective amount of a pharmaceutical composition comprising a peptide of 6 to 25 amino acids comprising SEQ ID NO:
- 1 (KRRKLR), or a functional analog thereof, the peptide comprising:
- (i) a C-terminal amid group or (ii) a C-terminal amid group and an N-terminal acyl group, thereby treating the subject in need of wound healing.
A method for treating a subject in need of induction of coagulation, the method comprising administering to said subject a therapeutically effective amount of a pharmaceutical composition comprising a peptide of 6 to 25 amino acids comprising SEQ ID NO:
- 1 (KRRKLR), or a functional analog thereof, the peptide comprising:
- (i) a C-terminal amid group or (ii) a C-terminal amid group and an N-terminal acyl group, thereby treating the subject in need of induction of coagulation.
-18. (canceled)
-22. (canceled)
(canceled)
Dependencies are inferred from the claim text.